AC
TGTX icon

Allstate Corporation’s TG Therapeutics TGTX Stock Holding History

Allstate Corporation’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$543K Buy
+9,879
New +$404K 0.01% 992
2021
Q3 		– Sell
-6,949
Closed -$270K – 720
2021
Q2 		$270K Buy
6,949
+4
+0.1% +$157 0.01% 669
2021
Q1 		$335K Hold
6,945
– – 0.01% 644
2020
Q4 		$361K Buy
+6,945
New +$235K 0.01% 584

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Allstate Corporation's TGTX Position: Q2 2026 in Review

Allstate Corporation opened a new position in TG Therapeutics (TGTX) in Q2 2026: 9,879 shares worth $543K. The stake represents 0.01% of the portfolio and ranks #992 among its holdings. This is a return to the name: Allstate Corporation previously reported a position in TGTX as recently as Q2 2021.

Allstate Corporation first reported a position in TGTX in Q4 2020 and has held it in 4 quarters since. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Allstate Corporation held 9,879 shares of TG Therapeutics worth $543K as of Q2 2026.
  • TG Therapeutics was a new Allstate Corporation position in Q2 2026.
  • TG Therapeutics made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #992 holding.
  • Allstate Corporation first reported a position in TG Therapeutics in Q4 2020 and has held it in 4 quarters since.
  • 430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.